Boston Partners Purchases 139,132 Shares of Teleflex Incorporated (NYSE:TFX)

Boston Partners grew its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 1,561.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 148,042 shares of the medical technology company's stock after buying an additional 139,132 shares during the period. Boston Partners owned 0.32% of Teleflex worth $26,351,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Victory Capital Management Inc. boosted its holdings in shares of Teleflex by 364.6% in the third quarter. Victory Capital Management Inc. now owns 35,370 shares of the medical technology company's stock valued at $8,748,000 after acquiring an additional 27,757 shares in the last quarter. CIBC Asset Management Inc lifted its position in Teleflex by 8.1% in the third quarter. CIBC Asset Management Inc now owns 6,866 shares of the medical technology company's stock worth $1,698,000 after purchasing an additional 517 shares during the period. Natixis Advisors LLC boosted its stake in Teleflex by 4.7% during the 3rd quarter. Natixis Advisors LLC now owns 20,916 shares of the medical technology company's stock valued at $5,173,000 after purchasing an additional 937 shares in the last quarter. Mutual of America Capital Management LLC increased its position in shares of Teleflex by 137.4% during the 3rd quarter. Mutual of America Capital Management LLC now owns 14,128 shares of the medical technology company's stock valued at $3,494,000 after purchasing an additional 8,176 shares during the period. Finally, Thrivent Financial for Lutherans increased its position in shares of Teleflex by 21.3% during the 3rd quarter. Thrivent Financial for Lutherans now owns 21,303 shares of the medical technology company's stock valued at $5,269,000 after purchasing an additional 3,736 shares during the period. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analysts Forecast Growth

A number of analysts recently commented on TFX shares. Bank of America downgraded shares of Teleflex from a "neutral" rating to an "underperform" rating and dropped their target price for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Truist Financial cut their price objective on Teleflex from $200.00 to $149.00 and set a "hold" rating for the company in a research report on Monday, March 3rd. Royal Bank of Canada cut Teleflex from an "outperform" rating to a "sector perform" rating and decreased their target price for the stock from $220.00 to $155.00 in a report on Friday, February 28th. Morgan Stanley cut their target price on Teleflex from $275.00 to $191.00 and set an "overweight" rating on the stock in a research report on Wednesday, March 5th. Finally, StockNews.com lowered Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, Teleflex presently has an average rating of "Hold" and an average price target of $182.63.

Teleflex Stock Up 0.0 %

Shares of Teleflex stock traded up $0.06 during trading on Monday, hitting $141.62. 1,276,248 shares of the stock traded hands, compared to its average volume of 548,688. The stock has a market cap of $6.57 billion, a P/E ratio of 28.16, a PEG ratio of 1.73 and a beta of 1.21. The company has a fifty day moving average price of $163.17 and a two-hundred day moving average price of $193.68. Teleflex Incorporated has a twelve month low of $128.55 and a twelve month high of $249.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Equities research analysts predict that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were given a $0.34 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 0.96%. Teleflex's dividend payout ratio is 95.77%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.